Galcanezumab for the prevention of high frequency episodic and chronic migraine in real life in Italy: a multicenter prospective cohort study (the GARLIT study).
Fabrizio VernieriClaudia AltamuraNicoletta BrunelliCarmelina Maria CostaCinzia AuriliaGabriella EgeoLuisa FofiValentina FavoniGiulia PierangeliCarlo LovatiMarco AguggiaFlorindo d'OnofrioAlberto DorettiPaola Di FioreCinzia FinocchiRenata RaoFrancesco BonoAngelo RanieriMaria AlbaneseSabina CevoliPiero Barbantinull nullPublished in: The journal of headache and pain (2021)
ClinicalTrials.gov NCT04803513 .